Dale N. Gerding, MD

Research Physician
Edward Hines, Jr. Veterans Affairs Hospital

Disclosure(s): Destiny Pharma plc.: Advisor/Consultant

Poster(s):

• 221 - Assessment and Proposed Revision of Clinical Trial Clostridioides difficile Infection Clinical Response and Outcomes Definitions
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 403 - Strain Epidemiology of Clostridioides difficile across Three Geographically Distinct Medical Centers in Chicago
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1669 - A US Based National Surveillance Study for the Susceptibility and Epidemiology of Clostridioides difficile Associated Diarrheal Isolates with Special Reference to Ridinilazole: 2020-2021
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET